Pricing Log in Create free account

Anbio Biotechnology (NNNN) vs Sanara MedTech Inc. (SMTI)

Anbio Biotechnology and Sanara MedTech Inc. are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $516.6M against $290.4M — 1.8× the size. Across the 9 metrics below, Anbio Biotechnology leads on 6 and Sanara MedTech Inc. on 3.

Valuation

Metric NNNN SMTI Medical Instruments & Supplies median
P/E — n/m 30.28
P/S — 2.50 2.49
P/B n/m 34.59 2.34
Price to free cash flow n/m 61.58 23.49
EV/EBITDA n/m 26.36 14.87
EV/Sales n/m 2.79 2.75
Earnings yield — (11.71%) 0.00%
Free cash flow yield 0.00% 1.62% 0.59%

Profitability

Metric NNNN SMTI Medical Instruments & Supplies median
Gross margin — 93.03% 53.60%
Operating margin — 7.67% 1.97%
Net margin — (29.15%) 0.00%
Free cash flow margin 0.00% 4.10% 2.36%
Return on equity 0.00% (147.79%) 0.00%
Return on assets 0.00% (38.13%) 0.00%
Return on invested capital 0.00% 13.49% 0.13%

Growth

Metric NNNN SMTI Medical Instruments & Supplies median
Revenue growth (TTM) — 12.96% 8.97%
EPS growth (last fiscal year) 150.00% (282.46%) 6.51%
Revenue growth, 5-year CAGR — 45.92% 8.85%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NNNN SMTI Medical Instruments & Supplies median
Debt to equity 0.00 5.86 0.10
Current ratio 344.45 2.58 2.47
Net debt to EBITDA (2.06) 2.55 0.97

Dividend

Metric NNNN SMTI Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric NNNN SMTI Medical Instruments & Supplies median
Market cap 516.57m 290.43m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack